Answers are grounded in this paper and cite their sources.
Cognitive changes including chemotherapy-related cognitive impairment (CRCI), are a prevalent side effect of chemotherapy, often colloquially referred to as ‘chemo brain’ or ‘chemo fog.’ A prior study reported a CRCI incidence rate of 75% in noncentral nervous system cancer survivors.1 CRCI has a detrimental impact on the quality of life (QOL) of cancer survivors. However, cognitive function is seldom discussed between cancer survivors and medical professionals, potentially due to a lack of awareness.
No takes yet. Share an insight, caveat, or question.
Mika Miyashita (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: